ISMO

This brand name is authorized in Germany, Italy, New Zealand, United Kingdom, South Africa

Active ingredients

The drug ISMO contains one active pharmaceutical ingredient (API):

1 Isosorbide mononitrate UNII LX1OH63030 - ISOSORBIDE MONONITRATE

Isosorbide mononitrate is an organic nitrate, which, in common with other cardioactive nitrates, is a vasodilator. It produces decreased left and right ventricular end-diastolic pressures to a greater extent than the decrease in systemic arterial pressure, thereby reducing afterload and especially the preload of the heart. Read about Isosorbide mononitrate

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
ISMO Retard prolonged-release tablet	Medicines and Medical Devices Safety Authority (NZ)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
C01DA14	Isosorbide mononitrate	C Cardiovascular system → C01 Cardiac therapy → C01D Vasodilators used in cardiac diseases → C01DA Organic nitrates
Discover more medicines within C01DA14

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: DE	Bundesinstitut für Arzneimittel und Medizinprodukte	Identifier(s): 02336997, 03348850
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 13854, 14106, 15223
Country: IT	Agenzia del Farmaco	Identifier(s): 025764010
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 13971, 4365
Country: ZA	Health Products Regulatory Authority	Identifier(s): R/7.1.4/136